Landauer, Inc. (NYSE:LDR) has earned a consensus broker rating score of 4.00 (Sell) from the two brokers that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong sell recommendation and one has given a hold recommendation to the company.
Brokerages have set a one year consensus price target of $44.50 for the company, according to Zacks. Zacks has also given Landauer an industry rank of 201 out of 265 based on the ratings given to related companies.
LDR has been the subject of several recent analyst reports. Zacks Investment Research lowered shares of Landauer from a “hold” rating to a “sell” rating in a report on Wednesday, May 17th. BidaskClub lowered shares of Landauer from a “sell” rating to a “strong sell” rating in a report on Tuesday.
Shares of Landauer (LDR) traded down 0.27% during trading on Friday, hitting $55.75. The stock had a trading volume of 17,841 shares. The stock has a market cap of $537.37 million, a price-to-earnings ratio of 27.75 and a beta of 1.30. Landauer has a one year low of $41.00 and a one year high of $56.30. The stock’s 50-day moving average price is $53.94 and its 200 day moving average price is $51.65.
Landauer (NYSE:LDR) last posted its quarterly earnings data on Tuesday, May 9th. The scientific and technical instruments company reported $0.54 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.04. The company had revenue of $39.12 million during the quarter. Landauer had a net margin of 12.82% and a return on equity of 79.41%. On average, equities analysts forecast that Landauer will post $1.79 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Thursday, July 6th. Stockholders of record on Friday, June 16th were paid a dividend of $0.275 per share. The ex-dividend date of this dividend was Wednesday, June 14th. This represents a $1.10 annualized dividend and a dividend yield of 1.97%. Landauer’s dividend payout ratio (DPR) is currently 54.46%.
Several hedge funds have recently added to or reduced their stakes in LDR. Metropolitan Life Insurance Co. NY boosted its stake in Landauer by 0.5% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 7,270 shares of the scientific and technical instruments company’s stock valued at $350,000 after buying an additional 36 shares during the period. Ngam Advisors L.P. boosted its stake in Landauer by 0.6% in the first quarter. Ngam Advisors L.P. now owns 10,120 shares of the scientific and technical instruments company’s stock valued at $493,000 after buying an additional 59 shares during the period. Atria Investments LLC boosted its stake in Landauer by 1.5% in the second quarter. Atria Investments LLC now owns 4,782 shares of the scientific and technical instruments company’s stock valued at $250,000 after buying an additional 71 shares during the period. Texas Permanent School Fund boosted its stake in Landauer by 1.0% in the second quarter. Texas Permanent School Fund now owns 7,038 shares of the scientific and technical instruments company’s stock valued at $368,000 after buying an additional 71 shares during the period. Finally, Arizona State Retirement System boosted its stake in Landauer by 2.0% in the first quarter. Arizona State Retirement System now owns 5,061 shares of the scientific and technical instruments company’s stock valued at $247,000 after buying an additional 100 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.
WARNING: This article was originally published by BNB Daily and is owned by of BNB Daily. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.baseball-news-blog.com/2017/08/13/zacks-landauer-inc-ldr-receives-average-rating-of-sell-from-analysts-updated.html.
Landauer Company Profile
Landauer, Inc is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Landauer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.